A Combined Epigenetic and Non-genetic Approach for Reprogramming Human Somatic Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Sep 3

PMID 20808872

Citations 22

Authors

Jinnuo Han

Perminder S Sachdev

Kuldip S Sidhu

Affiliations

Soon will be listed here.

Abstract

Reprogramming of somatic cells to different extents has been reported using different methods. However, this is normally accompanied by the use of exogenous materials, and the overall reprogramming efficiency has been low. Chemicals and small molecules have been used to improve the reprogramming process during somatic cell nuclear transfer (SCNT) and induced pluripotent stem (iPS) cell generation. We report here the first application of a combined epigenetic and non-genetic approach for reprogramming somatic cells, i.e., DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors, and human embryonic stem cell (hESC) extracts. When somatic cells were pretreated with these inhibitors before exposure to hESC (MEL1) extracts, morphological analysis revealed a higher rate of hESC-like colony formation than without pretreatment. Quantitative PCR (qPCR) demonstrated that pluripotency genes were upregulated when compared to those of somatic cells or treated with hESC extracts alone. Overall changes in methylation and acetylation levels of pretreated somatic cells suggests that epigenetic states of the cells have an effect on reprogramming efficiency induced by hESC extracts. KnockOutserum replacement (KOSR) medium (KO-SR) played a positive role in inducing expression of the pluripotency genes. hESC extracts could be an alternative approach to reprogram somatic cells without introducing exogenous materials. The epigenetic pre-treatment of somatic cells could be used to improve the efficiency of reprogramming process. Under differentiation conditions, the reprogrammed cells exhibited differentiation ability into neurons suggesting that, although fully reprogramming was not achieved, the cells could be transdifferentiated after reprogramming.

Citing Articles

Reprogramming by Cytosolic Extract of Human Embryonic Stem Cells to Improve Dopaminergic Differentiation Potential of Human Adipose Tissue-derived Stem Cells.

Mobasseri S, Javeri A, Taha M Basic Clin Neurosci. 2022; 13(2):247-255.

PMID: 36425950 PMC: 9682313. DOI: 10.32598/bcn.12.6.2069.1.

Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming.

Wang J, Chen S, Pan C, Li G, Tang Z Front Bioeng Biotechnol. 2022; 10:799152.

PMID: 35875485 PMC: 9301571. DOI: 10.3389/fbioe.2022.799152.

Small Molecule Treatments Improve Differentiation Potential of Human Amniotic Fluid Stem Cells.

Zentelyte A, Zukauskaite D, Jaceryte I, Borutinskaite V, Navakauskiene R Front Bioeng Biotechnol. 2021; 9:623886.

PMID: 33692988 PMC: 7937811. DOI: 10.3389/fbioe.2021.623886.

Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.

Stewart M, Langer R, Jensen K Chem Rev. 2018; 118(16):7409-7531.

PMID: 30052023 PMC: 6763210. DOI: 10.1021/acs.chemrev.7b00678.

Embryonic germ cell extracts erase imprinted genes and improve the efficiency of induced pluripotent stem cells.

Hu J, Zhao Q, Feng Y, Li N, Gu Y, Sun R Sci Rep. 2018; 8(1):10955.

PMID: 30026469 PMC: 6053380. DOI: 10.1038/s41598-018-29339-0.

References

Cowan C, Atienza J, Melton D, Eggan K . Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309(5739):1369-73. DOI: 10.1126/science.1116447. View

Kawamura T, Suzuki J, Wang Y, Menendez S, Morera L, Raya A . Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009; 460(7259):1140-4. PMC: 2735889. DOI: 10.1038/nature08311. View

Kimura H, Tada M, Nakatsuji N, Tada T . Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol. 2004; 24(13):5710-20. PMC: 480906. DOI: 10.1128/MCB.24.13.5710-5720.2004. View

Hattori N, Nishino K, Ko Y, Hattori N, Ohgane J, Tanaka S . Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem. 2004; 279(17):17063-9. DOI: 10.1074/jbc.M309002200. View

Dean W, Santos F, Stojkovic M, Zakhartchenko V, Walter J, Wolf E . Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc Natl Acad Sci U S A. 2001; 98(24):13734-8. PMC: 61110. DOI: 10.1073/pnas.241522698. View

Cheng J, Dutra A, Takesono A, Garrett-Beal L, Schwartzberg P . Improved generation of C57BL/6J mouse embryonic stem cells in a defined serum-free media. Genesis. 2004; 39(2):100-4. DOI: 10.1002/gene.20031. View

Turek-Plewa J, Jagodzinski P . The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett. 2005; 10(4):631-47. View

Jackson M, Krassowska A, Gilbert N, Chevassut T, Forrester L, Ansell J . Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol. 2004; 24(20):8862-71. PMC: 517875. DOI: 10.1128/MCB.24.20.8862-8871.2004. View

Rajasingh J, Lambers E, Hamada H, Bord E, Thorne T, Goukassian I . Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res. 2008; 102(11):e107-17. PMC: 2435186. DOI: 10.1161/CIRCRESAHA.108.176115. View

10.

Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen A . Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008; 26(7):795-7. PMC: 6334647. DOI: 10.1038/nbt1418. View

11.

Hutchison C, Worman H . A-type lamins: guardians of the soma?. Nat Cell Biol. 2004; 6(11):1062-7. DOI: 10.1038/ncb1104-1062. View

12.

Wernig M, Zhao J, Pruszak J, Hedlund E, Fu D, Soldner F . Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008; 105(15):5856-61. PMC: 2311361. DOI: 10.1073/pnas.0801677105. View

13.

Bernstein B, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey D, Huebert D . Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005; 120(2):169-81. DOI: 10.1016/j.cell.2005.01.001. View

14.

Dashwood R, Myzak M, Ho E . Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis. 2005; 27(2):344-9. PMC: 2267878. DOI: 10.1093/carcin/bgi253. View

15.

Marion R, Strati K, Li H, Murga M, Blanco R, Ortega S . A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature. 2009; 460(7259):1149-53. PMC: 3624089. DOI: 10.1038/nature08287. View

16.

Eilertsen K, Power R, Harkins L, Misica P . Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer. Anim Reprod Sci. 2006; 98(1-2):129-46. DOI: 10.1016/j.anireprosci.2006.10.019. View

17.

Han J, Sidhu K . Current concepts in reprogramming somatic cells to pluripotent state. Curr Stem Cell Res Ther. 2008; 3(1):66-74. DOI: 10.2174/157488808783489480. View

18.

Schuler M, Green D . Mechanisms of p53-dependent apoptosis. Biochem Soc Trans. 2001; 29(Pt 6):684-8. DOI: 10.1042/0300-5127:0290684. View

19.

Buschmann T, Fuchs S, Lee C, Pan Z, Ronai Z . SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell. 2000; 101(7):753-62. DOI: 10.1016/s0092-8674(00)80887-9. View

20.

Alberio R, Johnson A, Stick R, Campbell K . Differential nuclear remodeling of mammalian somatic cells by Xenopus laevis oocyte and egg cytoplasm. Exp Cell Res. 2005; 307(1):131-41. DOI: 10.1016/j.yexcr.2005.02.028. View